Obesity treatment and GLP1Ra therapy - What Acute Care Providers Need to Know

Learning objectives:

  • Recognize and manage the acute complications and adverse effects of GLP-1 receptor agonists and related incretin therapies
  • Apply current multi-society and ADA 2026 guidance for periprocedural and inpatient management
  • Integrate an evidence-based framework for obesity as a chronic multisystem disease and mitigate weight stigma

  

       

Microsoft Teams meeting

Join: https://teams.microsoft.com/meet/248672901308876?p=gFxBj4ZSyEHKiWmmXv

Meeting ID: 248 672 901 308 876

Passcode: cQ76Fi9G

Dial in by phone

+1 571-307-5517

Phone conference ID: 405 114 64#

Microsoft Teams meeting

Join: https://teams.microsoft.com/meet/248672901308876?p=gFxBj4ZSyEHKiWmmXv

Meeting ID: 248 672 901 308 876

Passcode: cQ76Fi9G

Dial in by phone

+1 571-307-5517

Phone conference ID: 405 114 64#

Session date: 
10/01/2026 - 12:00pm to 1:00pm EDT
Location: 
Virtual
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
Please login or register to take this course.
Faculty List: 
Program Director(s)

Jay Potluri, MD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Pamela Brandt, DO, MHI, FACP

has no relevant financial relationships to disclose at this time.